School of Medicine
Showing 1,101-1,150 of 13,183 Results
-
Fernando E Boada
Professor of Radiology (Radiological Sciences Laboratory)
BioFernando Boada is a Professor of Radiology and Associate Chair for Basic Science Translational Research at Stanford University Medical School. [1] He joined Stanford in 2021 after being Professor of Radiology, Psychiatry and Neurosurgery at New York University Medical School and the Director of the Center for Advanced Imaging Innovation and Research. [1] Prior to joining NYU in 2012, Dr. Boada directed the MR Research Center (MRRC) at the University of Pittsburgh for ten years. [1] His research efforts have been focused on the development of novel MRI techniques for addressing open neuroimaging questions in a translational setting.
-
Christina Bodurow
Affiliate, Medicine - Med/Gastroenterology and Hepatology
BioChris has a proven record of accomplishment delivering results to pharmaceutical and scientific organizations, including 33 years of management experience at Eli Lilly and Company, within Lilly Research Laboratories (LRL), 3.5 years in a global leadership role at IQVIA, and now as Deputy Director and COO of a significant NIH/NIAID research grant at Stanford University Medical School.
Over the years, Chris has served as a leader of multiple global teams in drug development and R&D Operations, representing her organizations in multiple external settings, including scientific, academic, drug development and R&D Operations forums.
In, December 2017, Chris retired from Lilly as Sr. Director, External Sourcing, leading an enterprise-wide R&D operations group that partnered with LRL functions to assess, on-board, and govern third party organizations across the entire drug development value chain, from pre-clinical, through clinical, regulatory, safety, health outcomes, product and device development, and diagnostics. The division consolidated both corporate and external requirements to deliver high-quality, risk-based, third party governance, oversight and alliance management for the LRL Development organization.
In February 2019, Chris joined IQVIA as the Vice-President of Strategy & Operations for DSSR, and subsequently moved in the role of Vice-President, Global Regulatory Affairs.
Specialties: Pharmaceutical Development, R&D Operations, Molecule Submission/Approval/Launch, Product Lifecycle Planning and Development, R&D Business Systems design and delivery. Third Party Management, Women's Leadership Development. -
Alexandria Boehm
Richard and Rhoda Goldman Professor of Environmental Studies, Professor of Oceans and Senior Fellow at the Woods Institute for the Environment
BioI am interested in pathogens in the environment including their sources, fate, and transport in natural and engineered systems. I am interested in understanding of how pathogens are transmitted to humans through contact with water, feces, and contaminated surfaces. My research is focused on key problems in both developed and developing countries with the overarching goal of designing and testing novel interventions and technologies for reducing the burden of disease.
I am also interested broadly in coastal water quality where my work addresses the sources, transformation, transport, and ecology of biocolloids - specifically fecal indicator organisms, DNA, pathogens, and phytoplankton - as well as sources and fate of nitrogen. This knowledge is crucial to formulating new management policies and engineering practices that protect human and ecosystem health at the coastal margins. -
Alistair Boettiger
Associate Professor of Developmental Biology
Current Research and Scholarly InterestsMy lab focuses on investigating the role of three-dimensional genome organization in regulating gene expression and in shaping cell fate specification during development. We pursue this with advanced single-molecule imaging and transgenics.
-
Matthew Bogyo
Professor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur lab uses chemical, biochemical, and cell biological methods to study protease function in human disease. Projects include:
1) Design and synthesis of novel chemical probes for serine and cysteine hydrolases.
2) Understanding the role of hydrolases in bacterial pathogenesis and the human parasites, Plasmodium falciparum and Toxoplasma gondii.
3) Defining the specific functional roles of proteases during the process of tumorogenesis.
4) In vivo imaging of protease activity -
Bryan Bohman
Clinical Professor, Medicine - Primary Care and Population Health
BioBryan Bohman is Associate Chief Medical Officer for Workforce Health and Wellness. Additional roles include Clinical Professor of Medicine and of Anesthesiology, Co-Director of the Clinical Effectiveness Leadership Training (CELT) program and Senior Advisor to the WellMD Center.
Bryan trained at Stanford in internal medicine and anesthesiology. After two decades of clinical practice in community-based anesthesiology, he served as SHC's first elected Chief of Staff from 2008-2011.
As Chief of Staff, Dr. Bohman established Stanford’s wellness committee and subsequently shepherded the founding of its WellMD Center in 2015, serving as the Center’s interim Director until 2017. The Center’s aim is to advance faculty, trainee and care team wellbeing across Stanford Medicine while also serving as an international leader of scholarship in occupational wellbeing. Bryan also led the establishment in 2014 of the CELT program, which continues to serve as a driver of clinical quality improvement across Stanford Medicine.
Dr. Bohman’s primary areas of interest include occupational wellbeing, process improvement, and the reciprocal influences between quality improvement, healthcare system performance, and the occupational wellbeing of healthcare personnel. -
Brian Boitnott
Ph.D. Student in Biomedical Physics, admitted Autumn 2023
BioI am currently a Biomedical Physics PhD candidate in the Department of Radiology. In the two years prior to Stanford, I was at MIT Lincoln Laboratory, where I worked on airborne remote sensing systems and was on the core team developing a laser-ultrasound system for medical imaging.
My interests revolve around health technology and perception. I started in neuroscience, studying attention and cognitive control, and now work on designing systems and algorithms for sensing and processing biomedical signals. My broader interests are at the intersection between emerging technology innovation, translation, and long-term innovation strategy. -
MacKenzie Bolen
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. MacKenzie “Mack” Bolen’s defining research passion is to leverage accessible and modifiable lifestyle factors to mitigate neurodegenerative risk. During her undergraduate education at Austin College in Texas, she began pursuing her interest in neurodegeneration by conducting research focused on the neuroprotective benefits of the ketogenic diet. This work evolved into an honors thesis investigating markers of inflammation in saliva from contact sport athletes and culminated in a TEDx talk on sports-related brain injuries. These experiences cemented her desire to understand the minutiae of the brain and catalyzed her decision to pursue a Ph.D. in Neuroscience at the University of Florida (UF). During Mack’s training under Dr. MG. Tansey at UF, her dissertation work generated global collaborations centered on a multiomic approach that leverages machine learning to identify peripheral biomarkers and novel therapeutic targets to slow the onset or progression of Parkinson’s disease. A hallmark of Mack’s career has been participating in collaborative team science and mentorship of the next generation of scientists, where she has consistently mentored advanced and budding scientists within the Gainesville community and collaborated on several manuscripts from labs across the nation. In addition to her scholarly work, she regularly volunteered at the UF Neuromedicine Intensive Care Unit (Neuro ICU) while pursuing her Ph.D. to better understand the clinical perspective of neurodegeneration.
By blending her Ph.D. training and experiences in the Neuro ICU, Mack hopes to actively improve the treatment of individuals living with neurodegeneration and continue to push the frontier of medicine as a postdoctoral scholar in Neurology and Neurological Sciences at Stanford. Now under the mentorship of Dr. K. Poston, Mack will continue to access essential training at the intersection of immunology and Parkinson’s disease, via the investigation of the gut-brain axis. As a former collegiate soccer player, Mack loves to pretend to relive her glory days during rec-league on the weekends and can also be found struggling through a Yin yoga class. -
Sam Bollinger
Ph.D. Student in Cancer Biology, admitted Autumn 2021
BioOriginally from State College, Pennsylvania, Sam graduated with honors from Penn State University with a B.S. in Chemistry and a minor in Biology. He subsequently spent three years working at the Lankenau Institute for Medical Research for Dr. Ellen Heber-Katz. Sam hopes to expand the paradigm of cancer research and help to develop novel therapies for cancer and other ailments. He is also interested in optimization of physical and mental performance.
-
Paul Bollyky
Stanford Medicine Professor of Infectious Disease and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsBacteriophages, viruses that infect bacteria, are abundant in the human body. However, their contributions to human health and disease are largely unknown. The Bollyky Lab
studies interactions between phages and both their human and bacterial hosts with the goal of developing innovative strategies to improve human health. -
Anna Maria Bombardieri, MD, PhD, MSc
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMy research program focuses on the autonomic nervous system as a modifiable determinant of physiological resilience and recovery across acute and chronic disease states. I investigate sympathetic modulation as a therapeutic strategy, examining how regional anesthetic and neuromodulation techniques, including cervical sympathetic and stellate ganglion blocks, influence cerebral perfusion, cardiovascular regulation, neuroimmune interactions, and functional outcomes.
Through the integration of clinical trials, translational human physiology, and advanced physiologic monitoring, my work seeks to elucidate mechanisms of autonomic dysfunction and to develop evidence-based neuromodulation approaches for conditions such as aneurysmal subarachnoid hemorrhage, postural orthostatic tachycardia syndrome (POTS), and post-acute sequelae of COVID-19 (Long COVID). The long-term objective of this research is to advance interdisciplinary models of care and to translate autonomic science into therapeutic strategies that improve long-term patient outcomes. -
Serena Bonaretti
Physical Science Research Scientist, Rad/Musculoskeletal Imaging
BioPlease visit My Personal Site and the JOINT Group Website (Links on the right)
-
Melissa L Bondy
Stanford Medicine Discovery Professor, Professor of Epidemiology and Population Health and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsPrincipal Investigator, Discovery, Biology and Risk of Inherited Variants in Glioma, 1R01CA217105-01A1, NIH/NCI, 05/01/2018-06/30/2022, MPI (Contact PI)
Principal Investigator, Characterizing Germline and Somatic Alterations by Glioma Subtypes and Clinical Outcome, 1R01CA232754-01, 07/01/2019-06/30/2023, MPI (Contact PI)
Co-Leader (Project), SPORE in Brain Cancer, PI – Fred Lang (Sub with MD Anderson), 2 P50CA127001-11, 09/01/2019-08/31/2023
Co-Investigator, Stanford University Cancer Center, PI – Steve Artandi, P30 CA124435, NCI, 09/15/10-05/31/22
Co-Investigator, Ovarian Cancer Survival in African-American Women, PI, Joellen Schildkraut, R01 CA237318-01A1, NIH/NCI, 07/01/2020-06/31/2025 -
C. Andrew Bonham, MD, FACS
Associate Professor of Surgery (Abdominal Transplantation), Emeritus
Current Research and Scholarly InterestsTolerance induction in liver transplantation.
Hepatocyte transplantation. -
Bernardo Bonilauri
Instructor, Cardiovascular Institute
BioDr. Bernardo Bonilauri is a molecular biologist investigating the fundamental mechanisms of protein misfolding, cryptic peptides, and non-canonical codes in human biology and disease. He completed his postdoctoral training at the Stanford Cardiovascular Institute under the mentorship of Dr. Joseph C. Wu, after which he was appointed Instructor. In this role, he continues to develop advanced in vitro disease models to probe molecular and cellular processes underlying human pathology.
His research focuses on Transthyretin Amyloidosis (ATTR) and related protein misfolding disorders, applying multi-omics, structural biology, and stem cell–based platforms to dissect how pathogenic aggregates form and impair cellular function. In parallel, Dr. Bonilauri investigates microproteins encoded by small open reading frames (sORFs), with emphasis on their translation, subcellular localization, and biological functions in human cells. -
Hector Fabio Bonilla
Clinical Professor, Medicine - Infectious Diseases
BioAs a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
